Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives | Cancer Biology & Medicine
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors - ScienceDirect
Targeted therapies in lung cancer and Biomarkers
XL EGFR amp - Amplification Probe | MetaSystems Probes
Overcoming therapy resistance in EGFR-mutant lung cancer | Nature Cancer
The biology of EGFR mutations in lung cancer. In normal cells, binding... | Download Scientific Diagram
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer | Signal Transduction and Targeted Therapy
Frontiers | Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
Patients with advanced non‑small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real‑world data analysis
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer | Biomarker Research | Full Text
HER2 amplification in advanced NSCLC patients | OTT
Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: a prospective observational study | BMC Cancer | Full Text
Distinct types of EGFR gene amplification identified in non-small cell... | Download Scientific Diagram
A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy | Scientific Reports
EGFR pathway in NSCLC. Mutations, amplification or overexpression of... | Download Scientific Diagram
Cancers | Free Full-Text | Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling | Science
Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas | European Respiratory Society
EGFR mutations and other main aberrations in lung and brain tumors.... | Download Scientific Diagram
![PDF] Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a0d5cec155ea8ab0ca4a5986a520e5b80ca5796b/3-Figure2-1.png "PDF] Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification. | Semantic Scholar")
PDF] Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification. | Semantic Scholar
Cancers | Free Full-Text | MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
Frontiers | Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors
Current status of lung cancer
EGFR | Cancer Genetics Web
